fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..
speaking after a four-day inquest, the family of brigid cavanagh, who died on july 20, 2016, said the western health trust should be ashamed after the 83-year-old had died in "terror"..